efavirenz

ICAAC: New Drug Easier to Take than HIV Standard (CME/CE)

MedPage Today Infectious Disease  Thu, 09/22/2011 - 09:00

CHICAGO (MedPage Today) -- The recently approved HIV drug rilpivirine (Edurant) is easier to take for the first three months of therapy than the widely used efavirenz (Sustiva), a researcher said.


 

New Antiretroviral Drug Effective as First HIV Treatment (CME/CE...

MedPage Today Infectious Disease  Mon, 08/03/2009 - 16:35

The new antiretroviral raltegravir (Isentress) is an effective first treatment for HIV and suppresses HIV replication far more rapidly than efavirenz,, with fewer adverse events according to a study funded by the manufacturer


 

IAS: Raltegravir Sustains High-level Efficacy in HIV Trial (CME/...

MedPage Today Infectious Disease  Wed, 07/22/2009 - 11:14

CAPE TOWN (MedPage Today) -- The integrase inhibitor raltegravir (Isentress) appeared to be as effective with HIV patients as the standard treatment based on efavirenz (Sustiva), researchers reported here.


 

Stepped Dosing Lessens Neuropsychiatric Effects of Efavirenz (CM...

MedPage Today Infectious Disease  Mon, 07/06/2009 - 15:00

LITTLE FALLS, N.J. (MedPage Today) -- A stepwise dosing schedule eases the neuropsychiatric side effects of the HIV drug efavirenz (Sustiva), a randomized trial showed.